Clipperdist.com

MATERIAL SAFETY DATA SHEET
SECTION 1 - IDENTIFICATION OF PRODUCT AND COMPANY
Pfizer Inc
Emergency telephone
Pfizer Animal Health
Hours of operation
235 East 42nd Street
Telephone
New York, NY 10017
Trade names
Clavamox ® Tablets
Product name
Clavamox ® Tablets
Therapeutic use
Description
Amoxicillin tablets supplied in strip packs SECTION 2 - COMPOSITION
Ingredient(s) indicated as hazardous have been assessed under standardsfor workplace safety.
SECTION 3 - HAZARDS IDENTIFICATION
Signal word
WARNING!
Statements of hazard
MAY CAUSE SENSITIZATION BY INHALATION AND SKIN
CONTACT.

Eye effects
None known; however, direct contact with any foreign material may causeeye irritation.
Skin effects
Allergic skin reactions might occur following direct contact with thismaterial.
Inhalation effects
Not expected due to physical form. Repeated exposure to dust or mist mayproduce allergic reactions.
Ingestion effects
May cause allergic reaction in penicillin-sensitive individuals.
Known clinical effects
Individuals who are allergic to penicillin antibiotics might exhibit allergicreactions, possibly severe. SECTION 3 - HAZARDS IDENTIFICATION . continued
This document has been prepared in accordance with standards forworkplace safety, which require the inclusion of all known hazards of theproduct or its ingredients regardless of the potential risk. Theprecautionary statements and warnings included may not apply in allcases. Your needs may vary depending upon the potential for exposure inyour workplace.
SECTION 4 - FIRST AID MEASURES
Remove contaminated clothing and flush exposed area with water. Obtainmedical assistance if irritation occurs, which may be delayed. Immediately flush eyes with water for at least 15 minutes. If irritationoccurs or persists, get medical attention. Inhalation
Remove to fresh air. If not breathing, give artificial respiration. Ifdiscomfort persists, get medical attention.
Ingestion
SECTION 5 - FIRE FIGHTING MEASURES
General hazard
This material is not expected to support combustion. Toxic or corrosivegases are expected during a fire or heating of this material. Fire fighting instructions
Wear approved positive pressure, self-contained breathing apparatus andfull protective turn out gear. Move containers from fire area if possiblewithout increased personal risk. Dike area if possible to contain water forlater disposal. Extinguishing media
Use carbon dioxide, dry chemical, or water spray.
Flash point
Hazardous combustion
Toxic or corrosive gases including oxides of carbon, nitrogen, and sulfur products
are expected in fires involving this material.
SECTION 6 - ACCIDENTAL RELEASE MEASURES
Review Sections 3, 8 and 12 before proceeding with clean up.
Small spill
Sweep spilled material into an approved container for disposal. Clean spillarea thoroughly. Prevent discharge to drains. Large spill
Contain the source of the spill or leak if it is safe to do so. Scoop or shovelspilled material into a labeled container for disposal. Clean spill areathoroughly. Prevent discharge to drains. SECTION 7 - HANDLING AND STORAGE
General handling
IF TABLETS OR CAPSULES ARE CRUSHED AND/OR BROKEN,AVOID BREATHING DUST AND AVOID CONTACT WITH EYES,SKIN AND CLOTHING.
Storage conditions
Avoid prolonged storage at elevated temperatures (greater than roomtemperature, approximately 20 degrees C). Keep in tightly sealedcontainers in a well-ventilated area.
SECTION 8 - EXPOSURE CONTROLS/PERSONAL PROTECTION
Ventilation
Good general ventilation should be sufficient to control airborne levels.
Respiratory protection
Respirators are not required for normal use of this material.
Eye protection
Not required under normal conditions of use. Wear safety glasses orgoggles if eye contact is possible. Skin protection
Wear protective clothing with long sleeves to avoid routine skin contact. Wash hands and arms thoroughly after handling this material. Clean upspills immediately. Hand protection
Wear protective gloves to avoid routine skin contact.
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical form
Molecular weight
Molecular formula
Boiling point
Melting point
Vapor pressure
Water solubility
Solvent solubility
SECTION 10 - STABILITY AND REACTIVITY
Reactivity
SECTION 10 - STABILITY AND REACTIVITY . continued
Conditions to avoid
Direct sunlight, conditions that might generate heat and dispersion as adust cloud Incompatibilities
Hazardous
decomposition
products

Hazardous
polymerization
SECTION 11 - TOXICOLOGY INFORMATION
Acute toxicity
Not determined for this mixture. May cause eye irritation based oncomponents.
Not determined for this mixture. Irritation may occur based on components.
Inhalation
Not determined for this mixture. However, allergic reactions might occurbased on effects of amoxicillin. Ingestion
Not determined for this mixture. The rat oral LD50 is expected to begreater than 2000 mg/kg based on toxicities of individual components andconcentrations present.
Mutagenicity
This mixture is not expected to be mutagenic, based on effects of individual components. Sensitization
Sensitization (allergic skin reaction) may occur, based on effects ofindividual components.
Subchronic effects
Chronic effects/
carcinogenicity
Carcinogen status
None of the components of this formulation is listed as a carcinogen byIARC, NTP or OSHA. Reproductive effects
Not determined for this mixture. Components in this mixture are unlikelyto produce reproductive effects in humans at levels encounteredoccupationally. SECTION 11 - TOXICOLOGY INFORMATION . continued
Teratogenicity
Not determined for this mixture. Components in this mixture are unlikelyto produce developmental effects in humans at levels encounteredoccupationally. At increased risk from
exposure
Additional information
This mixture contains material that is a penicillin antibiotic.
SECTION 12 - ECOLOGICAL INFORMATION
Environmental overview
Penicillins are susceptible to degradation by a number of microorganismsfound in wastewater treatment plants and the general environment.
Resulting degradation products are readily mineralized by environmentalmicroorganisms. SECTION 13 - DISPOSAL INFORMATION
Disposal procedure
Collect for recycling or recovery, if possible. Observe all local andnational regulations when disposing of this material. Dispose of materialon site in a licensed chemical incinerator, if allowed by the incineratorpermit. If no on-site incinerator is available, dispose of material in alicensed commercial chemical incinerator.
SECTION 14 - TRANSPORTATION INFORMATION
SECTION 15 - REGULATORY INFORMATION
EU Classification
EU Labelling
EU Label Pictogram(s)
Risk phrases
R42 - May cause sensitisation by inhalation. R43 - May cause sensitization by skin contact.
Safety phrases
S22 - Do not breathe dust. S24 - Avoid contact with skin. S36/37 - Wear suitable protective clothing and gloves. SECTION 15 - REGULATORY INFORMATION . continued
Canadian WHMIS
This product has been classified in accordance with the hazard criteria ofthe CPR and the MSDS contains all of the information required by theCPR.
SECTION 16 - OTHER
Disclaimer
Pfizer Inc believes that the information contained in this Material
Safety Data Sheet is accurate, and while it is provided in good faith, it
is without a warranty of any kind, expressed or implied.

Source: http://www.clipperdist.com/sites/default/files/ClavamoxTabs.pdf

Tegdn, sensitivity reducing ingredient for nitrocellulose based propellants

TEGDN, Sensitivity reducing ingredient for nitrocellulose based Propellants Jaana Suuronen, EURENCO Vihtavuori, Ruutitehtaantie 80, FI-41330 VIHTAVUORI, 1. Background Nitroglycerin is an important and widely used component of explosive materials. In double base propellants it is a main component in addition to nitrocellulose and stabilizers. However, Nitroglycerin is dangerous to ha

Microsoft word - experts reshape treatment guide for cholesterol.docx

Experts Reshape Treatment Guide for Cholesterol By GINA KOLATA Published: November 12, 2013 663 Comments The nation’s leading heart organizations released new guidelines on Tuesday that will fundamentally reshape the use of cholesterol-lowering statin medicines, which are now prescribed for a quarter of Americans over 40. Patients on statins will no longer need to lower their cholesterol levels

Copyright © 2011-2018 Health Abstracts